BAG5 Protein
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Bcl-2-Associated Athanogene 5</th></tr>
<tr><td><strong>Protein Symbol</strong></td><td>BAG5</td></tr>
<tr><td><strong>Full Name</strong></td><td>Bcl-2-associated athanogene 5</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>BAG5</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q32.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>10527</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9NSY4</td></tr>
<tr><td><strong>Protein Length</strong></td><td>211 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>23,500 Da</td></tr>
<tr><td><strong>Family</strong></td><td>BAG family, Hsp70 co-chaperones</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
S100B is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of S100B is associated with neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), Parkinson's disease, and related disorders.
Introduction
...
BAG5 Protein
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Bcl-2-Associated Athanogene 5</th></tr>
<tr><td><strong>Protein Symbol</strong></td><td>BAG5</td></tr>
<tr><td><strong>Full Name</strong></td><td>Bcl-2-associated athanogene 5</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>BAG5</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q32.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>10527</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9NSY4</td></tr>
<tr><td><strong>Protein Length</strong></td><td>211 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>23,500 Da</td></tr>
<tr><td><strong>Family</strong></td><td>BAG family, Hsp70 co-chaperones</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
S100B is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of S100B is associated with neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), Parkinson's disease, and related disorders.
Introduction
BAG5 (Bcl-2-associated athanogene 5) is a member of the BAG family of co-chaperones that regulate the ATPase activity of Hsp70/Hsc70 molecular chaperones[@takayama1999]. The BAG family consists of six members (BAG1-6) in humans, each characterized by a conserved C-terminal BAG domain that mediates interaction with the ATPase domain of Hsp70[@briknarov2001]. BAG5 is unique among BAG proteins as it contains multiple BAG domains and functions as a nucleotide exchange factor (NEF) for Hsp70 family proteins[@beeger2003].
Beyond its role in protein folding and quality control, BAG5 has emerged as an important regulator of neuronal survival and mitochondrial quality control, with particular relevance to Parkinson's disease and other neurodegenerative disorders[@glick2021].
Gene Structure
The BAG5 gene is located on chromosome 14q32.33 and consists of 17 exons encoding a 211-amino acid protein[@lee2002]. The gene spans approximately 13 kb and exhibits ubiquitous expression with highest levels in brain, heart, and skeletal muscle.
Protein Structure
BAG5 contains several functional domains:
- N-terminal region: Contains multiple BAG domains (BAG1-5 repeats)
- BAG domains (residues 26-211): Conserved ~110 amino acid domains that bind to the ATPase domain of Hsp70
- Nuclear localization signals: Present in some isoforms
- Phosphorylation sites: Multiple serine/threonine residues subject to regulatory phosphorylation[@kaye2000]
The multiple BAG domains allow BAG5 to simultaneously interact with multiple Hsp70 molecules, forming a bridge between Hsp70 substrates and the protein quality control machinery.
Molecular Functions
Hsp70 Co-chaperone Activity
BAG5 functions as a nucleotide exchange factor for Hsp70/Hsc70:
ATPase regulation: BAG5 binds to the ATPase domain of Hsp70, promoting ATP release (ADP release step)
Substrate release: Facilitates substrate release from Hsp70 after folding
Chaperone cycle coordination: Works in concert with J-domain proteins (Hsp40 co-chaperones) to regulate the Hsp70 cycle[@young2003]Anti-apoptotic Function
BAG5 inhibits [apoptosis](/entities/apoptosis) through multiple mechanisms:
- Direct interaction with Bcl-2 family proteins
- Inhibition of caspase activation
- Protection against various apoptotic stimuli
- Preservation of mitochondrial membrane potential[@takayama1997]
Protein Quality Control
- Targeting misfolded proteins for degradation
- Coordination with the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system)
- [Autophagy](/entities/autophagy) regulation
Brain Expression
In the central nervous system, BAG5 is expressed in:
- [Neurons](/entities/neurons): High expression in cortical neurons, hippocampal pyramidal neurons, and dopaminergic neurons of the substantia nigra
- [Astrocytes](/entities/astrocytes): Moderate expression
- [Microglia](/entities/microglia): Low baseline expression
- Oligodendrocytes: Present but lower levels[@carra2008]
Subcellular localization is predominantly cytoplasmic, with some nuclear localization in neurons.
Role in Neurodegeneration
Parkinson's Disease
BAG5 has emerged as an important regulator in Parkinson's disease pathogenesis:
PINK1/Parkin Pathway
BAG5 interacts with and regulates the PINK1/Parkin mitophagy pathway:
- Parkin regulation: BAG5 directly binds to Parkin and inhibits its E3 ubiquitin ligase activity[@che2012]
- PINK1 stabilization: BAG5 affects PINK1 stability on the mitochondrial surface
- Mitophagy modulation: Alters the timing and efficiency of mitophagy initiation
Mitochondrial Quality Control
BAG5 plays critical roles in mitochondrial maintenance:
- Mitochondrial protein quality control: Helps clear damaged mitochondrial proteins
- Mitochondrial dynamics: Influences fission/fusion balance
- ATP production: Maintains mitochondrial function under stress
- Mitochondrial membrane potential: Protects against depolarization[@wang2014]
Dopaminergic Neuron Survival
- BAG5 protects dopaminergic neurons from mitochondrial toxins
- Knockdown of BAG5 increases vulnerability to MPTP and 6-OHDA
- Overexpression provides neuroprotection in cellular models[@xu2016]
Alzheimer's Disease
BAG5 involvement in Alzheimer's disease:
- [Tau](/proteins/tau) processing: Modulates Hsp70-mediated tau refolding and degradation
- Amyloid-beta toxicity: Influences [Aβ](/proteins/amyloid-beta)-induced neuronal death
- Protein homeostasis: Maintains proteostasis in AD-vulnerable neurons[@chen2010]
Amyotrophic Lateral Sclerosis (ALS)
- BAG5 levels are altered in ALS models and patient tissue
- May influence [TDP-43](/proteins/tdp-43) proteinopathy
- Mitochondrial protection in motor neurons[@crippa2016]
Huntington's Disease
- Mutant [huntingtin](/proteins/huntingtin) aggregation affects BAG5 function
- Altered Hsp70-BAG5 dynamics in HD
- Potential therapeutic target[@rinaldi2015]
Mechanistic Pathways
Mitophagy Regulation
Mermaid diagram (expand to render)
Anti-apoptotic Pathway
BAG5 inhibits apoptosis through:
Interaction with Bcl-2 family proteins
Inhibition of caspase-3 activation
Preservation of mitochondrial integrity
Modulation of Akt survival signalingAnimal Models
Knockout Studies
- BAG5 knockout mice are viable with subtle neurological phenotypes
- Enhanced vulnerability to mitochondrial toxins
- Impaired stress response[@yin2017]
Transgenic Models
- Neuronal BAG5 overexpression protects against MPTP
- Improved mitochondrial function in PD models
Therapeutic Implications
Biomarker Potential
- BAG5 levels in CSF may reflect neuronal health
- Peripheral blood monocyte BAG5 as potential biomarker
Therapeutic Targets
- Small molecule modulators: Compounds that enhance BAG5 function
- Gene therapy: AAV-mediated BAG5 delivery to neurons
- Protein-protein interaction inhibitors: Targeting BAG5-Parkin interaction[@mclean2018]
Interacting Proteins
| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| Hsp70/Hsc70 | Direct binding | Nucleotide exchange |
| Parkin | Direct binding | E3 ligase inhibition |
| PINK1 | Functional interaction | Mitophagy regulation |
| Bcl-2 | Direct binding | Anti-apoptotic |
| Hsp40 (DNAJB proteins) | Co-chaperone complex | Substrate targeting |
See Also
- [BAG5 Gene](/genes/bag5)
- [Parkin Protein](/proteins/parkin)
- [PINK1 Protein](/proteins/pink1-protein)
- [HSP70 Protein](/proteins/hsp70-protein)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Mitophagy](/mechanisms/mitophagy)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Protein Quality Control](/mechanisms/protein-quality-control-network)mechanisms/protein-quality-control-network)
External Links
- [NCBI Gene: BAG5](https://www.ncbi.nlm.nih.gov/gene/10527)
- [UniProt: Q9NSY4](https://www.uniprot.org/uniprot/Q9NSY4)
- [Ensembl: ENSG00000173578](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173578)
Background
The study of Bag5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Takayama S, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/9920091/)
[Briknarová K, et al, (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11276254/)
[Beeger S, et al, (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12937032/)
[Glick D, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33830333/)
[Lee BG, et al, (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12036296/)
[Kaye FJ, et al, (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/11007871/)
[Young JC, et al, (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/14668333/)
[Takayama S, et al, (1997) (1997)](https://pubmed.ncbi.nlm.nih.gov/9244297/)
[Carra S, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18665308/)
[Che X, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22535959/)
[Wang HQ, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24991828/)
[Xu Z, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/26767618/)
[Chen Y, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20594265/)
[Crippa V, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27228345/)
[Rinaldi C, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25498972/)
[Yin J, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28209987/)
[McLean PJ, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29541902/)